http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1020801

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 802
issn 1179-1918
1173-2563
issueIdentifier 11
pageRange 797-802
publicationName Clinical Drug Investigation
startingPage 797
bibliographicCitation van Giersbergen PL, Dingemanse J. Effect of gender on the tolerability, safety and pharmacokinetics of clazosentan following long-term infusion. Clin Drug Investig. 2007;27(11):797–802. doi: 10.2165/00044011-200727110-00006. PMID: 17914898.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db2ab8e85f776afbe91a6f77ad8c4932
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6dac5c98be0aad4ebb37cd9a579bdde2
date 200711
identifier https://doi.org/10.2165/00044011-200727110-00006
https://pubmed.ncbi.nlm.nih.gov/17914898
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33140
https://portal.issn.org/resource/ISSN/1179-1918
https://portal.issn.org/resource/ISSN/1173-2563
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
title Effect of Gender on the Tolerability, Safety and Pharmacokinetics of Clazosentan Following Long-Term Infusion
discusses http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0028780
http://id.nlm.nih.gov/mesh/M0018260
http://id.nlm.nih.gov/mesh/M0006497
http://id.nlm.nih.gov/mesh/M0020790
http://id.nlm.nih.gov/mesh/M0021253
http://id.nlm.nih.gov/mesh/M0587498
http://id.nlm.nih.gov/mesh/M0499083
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16212950
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8e38613f28d11a079c0276d233e37ef4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433095

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128483327

Total number of triples: 37.